Bajaj Healthcare launches ‘Ivejaj’ tablets for Covid treatment, Top Health News | Latest Health & Healthcare Industry Information and Updates: ET HealthWorld : ETHealthworld.com

The company has received approval from India’s drug regulator DCGI to manufacture and market the tablets, it said in a BSE filing., The company has received approval from India’s drug regulator DCGI to manufacture and market the tablets, it said in a BSE filing., , Read More